Condition
NHL clinical trials and research
As of November 12, 2026, Find a Trial lists 6 NHL clinical trials that are recruiting, at sites in 2 countries (most in China (4), United States (2)). By phase: Phase 1 (2), Phase 1/2 (2), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2Countries
Newest NHL clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| HSK47977 tablets for adults with relapsed or refractory non-Hodgkin's lymphoma. | Phase 1 | Tianjin | Recruiting | Dec 16, 2025 |
| Testing FD-001 for recurrent or refractory blood cancers | Phase 1 | Chengdu, Sichuan | Recruiting | Dec 12, 2024 |
| CMOP±R therapy for newly diagnosed non-Hodgkin's lymphoma | Phase 2 | Suzhou, Jiangsu | Recruiting | Jul 3, 2024 |
| IDP-023 treatment for advanced blood cancers | Phase 1/2 | Los Angeles, California and 11 other locations | Recruiting | Nov 7, 2023 |
| Evaluating IM19 CAR-T cell therapy for patients with recurrent Non-Hodgkin's Lymphoma | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Jun 19, 2020 |
| Combining acalabrutinib with standard chemotherapy for untreated aggressive B-cell lymphoma | Phase 2 | Bethesda, Maryland | Recruiting | Jul 1, 2019 |
All recruiting trials (6)
-
HSK47977 tablets for adults with relapsed or refractory non-Hodgkin's lymphoma.
This Phase 1 study will test whether oral HSK47977 tablets are safe, how the body handles them, and whether they help adults with relapsed or refractory non-Hodgkin's lymphoma.
-
Testing FD-001 for recurrent or refractory blood cancers
This study is testing a new medication called FD-001 to see if it can help people with tough-to-treat blood cancers like acute myeloid leukemia and non-Hodgkin lymphoma.
-
CMOP±R therapy for newly diagnosed non-Hodgkin's lymphoma
This study tests CMOP±R in adults with newly diagnosed non-Hodgkin's lymphoma to see if the treatment is safe and effective.
-
IDP-023 treatment for advanced blood cancers
This study is testing a new treatment called IDP-023, which uses special immune cells alone and with other medications to see if it can help people with advanced blood cancers like multiple myeloma and non-Hodgkin lymphoma.
-
Evaluating IM19 CAR-T cell therapy for patients with recurrent Non-Hodgkin's Lymphoma
This study is testing a new CAR-T cell therapy called IM19 to see if it can safely help adults with recurrent Non-Hodgkin's Lymphoma.
-
Combining acalabrutinib with standard chemotherapy for untreated aggressive B-cell lymphoma
This study is testing if adding a new drug called acalabrutinib to standard chemotherapy can help people with untreated aggressive B-cell lymphoma get better results.
Related topics
Quick answers
How many NHL clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (4 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.